Top Markets
Coin of the day
Safe Orthopaedics SA Safe Orthopaedics SA

Safe Orthopaedics SA

ALSAF
Rank in Stocks #21227
Safe Orthopaedics SA, a medical technology company, develops and markets... Safe Orthopaedics SA, a medical technology company, develops and markets sterile implants and single-use instruments for the treatment of spinal fracture pathologies in France and internationally. The company offers SteriSpine PS, an all-round kit for the treatment of spinal fractures and degenerative pathologies; and SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems. It also provides SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. The company was founded in 2010 and is headquartered in Éragny-sur-Oise, France.
Share Price
$0.94892414
Market Cap
$84.62
Change (1 day)
0.00%
Change (1 year)
19,787.42%
Country
FR
Trade Safe Orthopaedics SA (ALSAF)

Category

Revenue for Safe Orthopaedics SA (ALSAF)
Revenue in Jun 2024 TTM: $5.91M
According to Safe Orthopaedics SA latest financial reports the company's current revenue (TTM) is $5.91M. In 2022 the company made a revenue of $6.29M an increase over the revenue in the year 2021 that was $5.18M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Safe Orthopaedics SA from 2012 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $5.91M -7.94%
2023 $6.42M 2.16%
2022 $6.29M 21.40%
2021 $5.18M 16.24%
2020 $4.45M -15.50%
2019 $5.27M 132,078.75%
2018 $3.99K 6.89%
2017 $3.73K 49.96%
2016 $2.49K -8.26%
2015 $2.71K 9.19%
2014 $2.48K -99.81%
2013 $1.33M 209.23%
2012 $430.03K 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$10.06B 170,125.39%
US
$33.43B 565,264.45%
FR
$4.14B 69,897.51%
DE
$5.91B 99,857.75%
JP
$21.92B 370,686.13%
US